Skip to main content
logo
Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
22.16
-0.28 (-1.25%)
At close: Feb 13, 2026, 4:00 PM EST
22.54
+0.38 (1.71%)
After-hours: Feb 13, 2026, 7:38 PM EST

Immunome Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
9.689.0414.02---
Revenue Growth (YoY)
-4.44%-35.50%----
Cost of Revenue
174.41129.5423.0923.11--
Gross Profit
-164.73-120.5-9.07-23.11--
Selling, General & Admin
42.1232.9619.6613.7911.094.78
Research & Development
----14.117.49
Operating Expenses
42.1232.9619.6613.7925.212.26
Operating Income
-206.85-153.46-28.73-36.9-25.2-12.26
Interest Expense
-----0.01-0.04
Interest & Investment Income
11.4812.842.720.01--
Other Non Operating Income (Expenses)
------5.54
EBT Excluding Unusual Items
-195.37-140.62-26-36.9-25.21-17.84
Other Unusual Items
----0.5-
Pretax Income
-222.74-292.96-106.81-36.9-24.71-17.84
Net Income
-222.74-292.96-106.81-36.9-24.71-17.84
Preferred Dividends & Other Adjustments
---0.62--
Net Income to Common
-222.74-292.96-106.81-37.52-24.71-17.84
Shares Outstanding (Basic)
79592012123
Shares Outstanding (Diluted)
79592012123
Shares Change (YoY)
47.92%195.51%63.64%5.10%240.41%209.85%
EPS (Basic)
-2.81-5.00-5.38-3.09-2.14-5.26
EPS (Diluted)
-2.81-5.00-5.38-3.09-2.14-5.26
Free Cash Flow
-191.84-117.97-8.4-28.94-18.31-12.72
Free Cash Flow Per Share
-2.42-2.01-0.42-2.39-1.59-3.75
Gross Margin
---64.71%---
Operating Margin
-2137.10%-1697.33%-204.94%---
Profit Margin
-2301.30%-3240.38%-761.92%---
Free Cash Flow Margin
-1982.00%-1304.80%-59.92%---
EBITDA
-204.56-151.89-28.27-36.48-24.45-11.51
EBITDA Margin
---201.68%---
D&A For EBITDA
2.291.570.460.420.760.76
EBIT
-206.85-153.46-28.73-36.9-25.2-12.26
EBIT Margin
---204.94%---
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q